Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Inventory Average (2022 - 2025)

Historic Inventory Average for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $39602.5.

  • bioAffinity Technologies' Inventory Average rose 4366.69% to $39602.5 in Q3 2025 from the same period last year, while for Sep 2025 it was $39602.5, marking a year-over-year increase of 4366.69%. This contributed to the annual value of $23046.0 for FY2024, which is 9185.81% up from last year.
  • Latest data reveals that bioAffinity Technologies reported Inventory Average of $39602.5 as of Q3 2025, which was up 4366.69% from $41376.5 recorded in Q2 2025.
  • Over the past 5 years, bioAffinity Technologies' Inventory Average peaked at $41376.5 during Q2 2025, and registered a low of $5627.5 during Q4 2022.
  • Over the past 4 years, bioAffinity Technologies' median Inventory Average value was $16911.8 (recorded in 2023), while the average stood at $20901.8.
  • Its Inventory Average has fluctuated over the past 5 years, first soared by 17553.1% in 2024, then skyrocketed by 4366.69% in 2025.
  • Quarter analysis of 4 years shows bioAffinity Technologies' Inventory Average stood at $5627.5 in 2022, then skyrocketed by 152.26% to $14196.0 in 2023, then soared by 86.57% to $26485.5 in 2024, then soared by 49.53% to $39602.5 in 2025.
  • Its Inventory Average was $39602.5 in Q3 2025, compared to $41376.5 in Q2 2025 and $33195.0 in Q1 2025.